Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Direct antiglobulin test type, red blood cell distribution width, and estimated glomerular filtration rate for early prediction of in-hospital mortality of patients with COVID-19. Local targets link to admitted publications; unresolved targets remain external evidence.
Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases
10.1002/ajh.23356 · 2013 · External reference
Application of flow cytometry in detection of red-cell-bound IgG in coombs-negative AIHA
10.1080/10245330600915958 · 2006 · External reference
A new test for the detection of weak and “incomplete” RH agglutinins
1945 · External reference
10.5858/arpa.2015-0444-rs
10.5858/arpa.2015-0444-rs · External reference
DAT-negative autoimmune hemolytic anemia
10.1016/j.hoc.2021.11.004 · 2022 · External reference
Evaluation of the direct antiglobulin test (DAT) in the setting of mycoplasma pneumoniae infection
10.1001/jama.2018.1969 · 2018 · External reference
Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes
10.1182/blood.v50.2.195.195 · 1977 · External reference
Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID‐19)
10.1111/bjh.16892 · 2020 · External reference
COVID-19 associated with severe autoimmune hemolytic anemia
10.1111/trf.16226 · 2021 · External reference
10.1016/j.tracli.2021.05.010
10.1016/j.tracli.2021.05.010 · External reference
COVID‐19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation
10.1002/pbc.28382 · 2020 · External reference
Complications of autoimmune hemolytic anemia
10.1016/j.hoc.2021.12.003 · 2022 · External reference
10.1038/s41591-020-0897-1
10.1038/s41591-020-0897-1 · External reference
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19
10.1007/s00277-022-04921-9 · 2022 · External reference
Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19
10.1182/blood.2020006695 · 2020 · External reference
Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID‐19?
10.1111/bjh.16883 · 2020 · External reference
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
10.1038/s41467-021-22781-1 · 2021 · External reference
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19
10.1182/bloodadvances.2021005246 · 2022 · External reference
10.1172/jci141374
10.1172/jci141374 · External reference
10.1182/blood-2013-03-489245
10.1182/blood-2013-03-489245 · External reference
Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting
10.1016/j.blre.2019.100648 · 2020 · External reference
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias: severe, refractory and fatal autoimmune hemolytic anemias
10.1002/ajh.24047 · 2015 · External reference
10.1038/s41577-020-0320-7
10.1038/s41577-020-0320-7 · External reference
Rapidly progressing autoimmune hemolytic anemia in a pediatric patient with COVID-19
10.7759/cureus.45633 · 2023 · External reference
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible rbc product and glucocorticoids
10.1007/s00277-021-04457-4 · 2022 · External reference
Complement mediated hemolytic anemias in the COVID-19 era: case series and review of the literature
10.3389/fimmu.2021.791429 · 2021 · External reference
